Abstract: The present invention provides a method of efficiently manufacturing an emulsion that is improved in monodispersibility by a membrane emulsification method. The manufacturing method for an emulsion of the present invention includes circulating a mixed liquid containing a water phase and an oil phase in a circulation circuit including one or more tanks, a porous body, liquid-delivering means, and circulation pipes configured to connect the tanks, the porous body, and the liquid-delivering means so that the mixed liquid passes through the porous body a plurality of times, wherein the circulation circuit further includes a gas-separating device, and wherein the gas-separating device is configured to remove air bubbles from the mixed liquid therethrough.

Abstract: The present invention provides a method of manufacturing an emulsion that is more excellent in monodispersibility by a membrane emulsification method. The manufacturing method for an emulsion of the present invention is a manufacturing method for an emulsion, including circulating a mixed liquid containing a water phase and an oil phase in a circulation circuit including a plurality of tanks, a porous body, a liquid-delivering means, and circulation pipes configured to connect the tanks, the porous body, and the liquid-delivering means so that the mixed liquid passes through the porous body a plurality of times, wherein a tank to supply the mixed liquid to the circulation pipes toward the porous body and a tank to recover the mixed liquid that has passed through the porous body are different tanks.

Abstract: Lactic acid bacteria according to the present invention is configured to enter M cells. The lactic acid bacteria allow galectin-9 to bind thereto by filamentation, and thus, galectin-9 which has passed through and has been expressed in the M cells binds to the filament lactic acid bacteria. Also, lactic acid bacteria (Lactobacillus salivarius AI-001) are provided by allowing filament lactic acid bacteria, to which galectin-9 binds, to bind to IgE antibodies so as to regulate the immunity system.

Abstract: Lactic acid bacteria according to the present invention is configured to enter M cells. The lactic acid bacteria allow galectin-9 to bind thereto by filamentation, and thus, galectin-9 which has passed through and has been expressed in the M cells binds to the filament lactic acid bacteria. Also, lactic acid bacteria (Lactobacillus salivarius AI-001) are provided by allowing filament lactic acid bacteria, to which galectin-9 binds, to bind to IgE antibodies so as to regulate the immunity system.

Abstract: [Problem] To provide M cells having excellent strength and anti-allergy activity and an artificial skin sheet formed from the M cells. [Solution] GP2 contained in the M cells is transferred to the intracellular tight junction and galectin 9 is expressed in the M cells. Moreover, a structure is formed in which both GP2 and galectin 9 are present at the M cell surface.

Abstract: [Problem] To provide M cells having excellent strength and anti-allergy activity and an artificial skin sheet formed from the M cells. [Solution] GP2 contained in the M cells is transferred to the intracellular tight junction and galectin 9 is expressed in the M cells. Moreover, a structure is formed in which both GP2 and galectin 9 are present at the M cell surface.

Abstract: [Object] It is to provide a method and a kit capable of detecting or quantifying a target RNA simply and rapidly from trace amounts of RNA in a sample, in a case such as when one or more kinds of pathogenic microorganisms are to be detected or quantified. [Solving Means] The method comprises the steps of 1) synthesizing cDNA from a sample containing the target RNA using a liquid-phase primer having a promoter sequence and a reverse transcriptase to obtain a cDNA-RNA complex, 2) degrading the RNA of the complex, 3) synthesizing a double-stranded DNA via the cDNA obtained in the step 2) and the solid-phase primer, 4) synthesizing RNA from the double-stranded DNA, 5) synthesizing cDNA via the RNA obtained in the step 4) and the solid-phase primer to obtain a cDNA-RNA complex, 6) degrading the RNA of the complex obtained in step 5), 7) synthesizing a double-stranded DNA via the cDNA obtained in the step 6) and the liquid-phase primer, and 8) quantifying the double-stranded DNAs obtained in the steps 3) and 7).

Abstract: A photo-reactive composition layer is formed on a support with transparency while moving the support with transparency in one direction. The support is reversed as to be moved in a direction opposite to the one direction to generate a serpentine transport path, whereby the supports prior to reverse and subsequent to reverse face to each other serpentinely. Light from lamps for ultraviolet-ray emission is applied to the support, and every photo-reactive composition layer on the support serpentinely is photo-polymerized while light is transmitted through the support and the photo-reactive composition layer formed on the support.

Abstract: [Object] It is to provide a method and a kit capable of detecting or quantifying a target RNA simply and rapidly from trace amounts of RNA in a sample, in a case such as when one or more kinds of pathogenic microorganisms are to be detected or quantified. [Solving Means] The method comprises the steps of 1) synthesizing cDNA from a sample containing the target RNA using a liquid-phase primer having a promoter sequence and a reverse transcriptase to obtain a cDNA-RNA complex, 2) degrading the RNA of the complex, 3) synthesizing a double-stranded DNA via the cDNA obtained in the step 2) and the solid-phase primer, 4) synthesizing RNA from the double-stranded DNA, 5) synthesizing cDNA via the RNA obtained in the step 4) and the solid-phase primer to obtain a cDNA-RNA complex, 6) degrading the RNA of the complex obtained in step 5), 7) synthesizing a double-stranded DNA via the cDNA obtained in the step 6) and the liquid-phase primer, and 8) quantifying the double-stranded DNAs obtained in the steps 3) and 7).

Abstract: A vinyl chloride resin composition is prepared by (1) preparing an acrylic elastomer (A) by (a) polymerizing 30 to 50% by wt of an aromatic vinyl monomer in the presence of a polyfunctional cross-linking agent having at least one allyl group and a carboxylate anion surfactant as an emulsifier at a pH maintained between 7.0-9.5 and then (b) graft-polymerizing 50 to 70% by wt of an alkyl acrylate of 2 to 10 carbon atoms in the alkyl group onto said polymerized aromatic vinyl polymer in the presence of from 0.